"Alpha1-Adrenergic Receptors Positively Regulate Toll-Like Receptor Cytokine Production from Human Monocytes and Macrophages

Author(s): Grisanti LA, Woster AP, Dahlman J, Sauter ER, Combs CK, et al.

Abstract

Catecholamines released from the sympathetic nervous system in response to stress or injury affect expression of inflammatory cytokines generated by immune cells. α(1)-Adrenergic receptors (ARs) are expressed on innate immune cell populations, but their subtype expression patterns and signaling characteristics are not well characterized. Primary human monocytes, a human monocytic cell line, and monocyte-derived macrophage cells were used to measure expression of the proinflammatory mediator interleukin (IL)-1β responding to lipopolysaccharide (LPS) in the presence or absence of α(1)-AR activation. Based on our previous findings, we hypothesized that α(1)-AR stimulation on innate immune cells positively regulates LPS-initiated IL-1β production. IL-1β production in response to LPS was synergistically higher for both monocytes and macrophages in the presence of the selective α(1)-AR agonist (R)-(-)-phenylephrine hydrochloride (PE). This synergistic IL-1β response could be blocked with a selective α(1)-AR antagonist as well as inhibitors of protein kinase C (PKC). Radioligand binding studies characterized a homogenous α(1B)-AR subtype population on monocytes, which changed to a heterogeneous receptor subtype expression pattern when differentiated to macrophages. Furthermore, increased p38 mitogen-activated protein kinase (MAPK) activation was observed only with concurrent PE and LPS stimulation, peaking after 120 and 30 min in monocytes and macrophages, respectively. Blocking the PKC/p38 MAPK signaling pathway in both innate immune cell types inhibited the synergistic IL-1β increase observed with concurrent PE and LPS treatments. This study characterizes α(1)-AR subtype expression on both human monocyte and macrophage cells and illustrates a mechanism by which increased IL-1β production can be modulated by α(1)-AR input.

Similar Articles

Pathophysiology and management of bowel dysfunction in multiple sclerosis

Author(s): Wiesel PH, Norton C, Glickman S, Kamm MA

Fatigue in MS is related to sympathetic vasomotor dysfunction

Author(s): Flachenecker P, Rufer A, Bihler I, Hippel C, Reiners K, et al.

"Is Fatigue in Patients with Multiple Sclerosis Related to Autonomic Dysfunction?" Clin Auto Res 10: 169-175

Author(s): Keselbrener L, Akselrod S, Ahiron A, Eldar M, Barak Y, et al.

"Clinical Screening of Autonomic Dysfunction in Multiple Sclerosis

Author(s): Hale LA, Nukada H, Du Plessis LJ, Peebles KC

Reflex control of immunity

Author(s): Tracey KJ

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis

Author(s): Birnbaum G, Cree B, Altafullah I, Zinser M, Reder AT

Inhibitory role for GABA in autoimmune inflammation

Author(s): Bhat R, Axtell R, Mitra A, Miranda M, Lock C, et al.

Effects of sedatives on noradrenaline release from the medial prefrontal cortex in rats

Author(s): Kubota T, Hirota K, Yoshida H, Takahashi S, Anzawa N, et al.

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin

Author(s): Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, et al.

The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice

Author(s): van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, et al.

Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung

Author(s): Giebelen IA, van Westerloo DJ, LaRosa GJ, de Vos AF, van der Poll T

Physiologic and functional responses of MS patients to body cooling

Author(s): Ku YT, Montgomery LD, Lee HC, Luna B, Webbon BW